Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Treatment of mucosal bleeding (epistaxis, gastrointestinal and menorrhagia) and joint bleeding remains problematic in clinically severe von Willebrand Disease (VWD). Patients are often unresponsive to treatment (e.g. desmopressin or antifibrinolytic therapy) and may require von Willebrand (VW) factor replacement therapy. There are little data on the use of prophylaxis in VWD and none applied in a prospective, treatment escalation design.

Detaljer

Författare
  • T Abshire
  • J Cox-Gill
  • C L Kempton
  • F W G Leebeek
  • M Carcao
  • P Kouides
  • S Donfield
  • Erik Berntorp
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Kardiologi
Originalspråkengelska
Sidor (från-till)1585-1589
TidskriftJournal of Thrombosis and Haemostasis
Volym13
Utgivningsnummer9
StatusPublished - 2015
PublikationskategoriForskning
Peer review utfördJa